Navigation Links
Hormone Inhibitor in Prostate Cancer Treatment

Two poster presentations at the ESMO Conference Lugano this week show that the drug, called abiraterone, reduced levels of prostate specific antigen, a marker of cancer activity, and shrank tumors in patients in whom hormone therapy had stopped working and also in patients who had previously been treated with chemotherapy.

For prostate cancer patients whose tumors have continued to grow despite medical or surgical castration, a new drug candidate that inhibits production of male hormones anywhere in the body is showing promise in early trials.

Male hormones such as testosterone are produced mainly in the testes, but are also produced by the adrenal gland and elsewhere in the body. These hormones can stimulate prostate cancer cells to grow, so the first treatment option for all men with prostate cancer that has spread, is to use chemical suppressants or surgery to inhibit testicular synthesis of male hormones.

However, this treatment does not block the production of male hormones elsewhere in the body. Abiraterone, a drug that is taken orally, inhibits an enzyme called CYP450c17, which is critical to the production of the male hormones not only in the testes, but also at other sources.

Dr. Alison Reid from The Institute of Cancer Research and Dr. Gerhardt Attard from The Institute and The Royal Marsden NHS Foundation Trust in London described two ongoing Phase II trials of the drug in men with advanced prostate cancer.

Men in both studies were given 1000mg of abiraterone daily. The first study treated men who had not previously received chemotherapy. So far 34 men have been treated, of whom 22 have seen their PSA levels drop at least 50% after 2 months. Some patients have also had shrinkage of their tumors (partial response).

This represents significant anti-tumor activity, the researchers say.

In the second study, the UK team studied 28 men whose cancer was growing despit
'"/>




Page: 1 2

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. Hormone replacement Therapy a headache
3. Ovarian cancer in relationship with Hormone therapy
4. Hormone contraceptives lead to bone problems
5. Hormone treatment helps obese people slim down
6. Hormone Deficiency Results In Miscarriage
7. Hormones Linked To Migraines
8. Hormone replacement therapy helps women
9. Decrease of Hunger Hormone after Obesity Surgery
10. Possible benefits of Hormone Replacement Therapy
11. Hormone replacement therapy improves sexual function
Post Your Comments:
(Date:10/6/2008)...-- Today, PARI Pharma GmbH will,unveil a prototype...ngle,dose ampoules to control medication used in t...it-dose ampoule that is required to operate the,ne...meets an unmet need by,reducing the risk of using ...ifying filling procedures, improving dose uniformi...
(Date:10/6/2008)...s presented at the American College of Gastroenter...Fla., demonstrated that TAK-390MR resulted in high...with more severe grades of erosive esophagitis (EE...Delayed Release (DDR) formulation, designed to pro...ration of acid suppression. , "These data are e...
(Date:10/6/2008)...ial supplement of the Oct. 15,journal Cancer for t...le-income countries to implement breast cancer pro...among women worldwide., "Guidelines for Internati...tion" developed by the Breast Health Global Initia...llocation -- based on countries,overall economic ...
(Date:10/6/2008)... organizers of Informex are,delighted to announce ...the,Pharmaceutical Industry, taking place November...ersey USA., The conference is chaired by David Ki...cil, and boasts an unparalleled panel of key indus...son, Bristol Myers Squibb,Genentech, Boehringer I...
Breaking Medicine News(10 mins):Health News:PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference 2Health News:Takeda's investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 3Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2
...turbing link between Reclast, made by Novartis AG ...ular heart rhythm , though only in a small number .... The signs of a problem seem to be more pronounc...t. But there was a hint of similar trouble in a fe...
...n Australian are succumbing to infections. And tha...e parents fall back on the day care centres. Th...stralian children found infectious diseases were t...italization of children under two. Researchers a...
...ast-feeding, there is no hard and fast rule as to ...mothers would be more than glad to endorse that v...le breast feeding, can prove too painful for mothe...se of Nicola Adolphe. Nicola accordingly, had a ho...
...e being fed contaminated feed is causing concern a...the rise for the past few years . The FDA is quick...e much human risk. This concern came to light aft...was investigated into and it came to light that th...
Other Medicine News:Health News:Anti-osteoporosis Drugs Could Result in Irregular Heart Rhythm, New Study 2Health News:New Research Promises To Take The Pain Off Breast Feeding 2Health News:New Research Promises To Take The Pain Off Breast Feeding 3Health News:Tainted Pet Food a Health Risk for Human? 2
(Date:10/6/2008)...J., Oct. 6 /- Pharmasset, I...mith, Ph.D., is joining the,Company as Vice Presid...ions. Dr. Smith will be responsible for all invest... Chief Financial Officer Kurt,Leutzinger., Most r... Biotechnology,Analyst at JPMorgan Securities, and...
(Date:10/6/2008)...ogy opens the door to the understanding of and pos...geing and cancer, BILLERICA, Mass., Oct. 6 /PRNew...release of the first ever analytical instrument fo...consumption and cytoplasmic,glycolysis in cells in...,for measuring cellular bioenergetics have been re...
(Date:10/6/2008)...al Associations Collaborate to Improve Patient Saf...- The American College of,Cardiology in collaborat...and the American Heart Association today released ... for reducing the risk of ulcers and,gastrointesti...l,anti-inflammatory drugs (NSAIDs) along with anti...
(Date:10/6/2008)...C Trial Showed REMICADE Therapy is More Likely to ...g Compared with Standard Immun...- Data presented for the first time,f...sease Naive to,Immunomodulators and Biologic Thera...ach to care of patients with moderate to severe Cr...
Breaking Medicine Technology:Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Studies Reveal Why Breast Cancer Hits Black Women Harder 7238 1Studies Reveal Why Breast Cancer Hits Black Women Harder 7238 2Studies Reveal Why Breast Cancer Hits Black Women Harder 7238 3University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 1University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 2Secretaries of Health and Public Welfare Recognize World Aids Day 3B Urge HIV Testing 7228 1Secretaries of Health and Public Welfare Recognize World Aids Day 3B Urge HIV Testing 7228 2Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 1Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 2Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 3Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 4Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 5
...h Breakthrough Will Aid in Developing Therapies to..., EMERYVILLE, Calif., May 10, 2007 /PRNewswire/ --... development company, announced,today the first me...tissues in animals through the pathway known as re... known mechanism by which excess,cholesterol can b...
...Italy--(BUSINESS WIRE)--May 14, 2007 - Acceleron P...g therapeutics for the,treatment of musculoskeleta...nounced results of a preclinical study with,ACE-03... increase,muscle mass and strength in normal mice ...1 inhibits negative regulators of muscle,to increa...
Other Medicine Technology:KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 2Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 3
Ohl periosteal elevators.
Seldin periosteal elevators.
Alexander periosteal elevators.
Langebeck periosteal elevators.
Medicine Products: